本页面由Tiger Trade Technology Pte. Ltd.提供服务

Beta Bionics, Inc.

17.98
+0.35001.99%
成交量:53.13万
成交额:964.19万
市值:8.01亿
市盈率:-10.91
高:18.56
开:17.89
低:17.71
收:17.63
52周最高:32.71
52周最低:8.80
股本:4,456.17万
流通股本:2,651.52万
量比:0.57
换手率:2.00%
股息:- -
股息率:- -
每股收益(TTM):-1.6486
每股收益(LYR):-1.8100
净资产收益率:-26.16%
总资产收益率:-16.67%
市净率:3.13
市盈率(LYR):-9.93

数据加载中...

2026/10/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/10/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/17

重要事件披露

Form 8-K - Current report
2026/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/16

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/09/16

重要事件披露

Form 8-K - Current report
2026/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/25

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities